Clinical Trial Update: A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating MK0217 for Paget's Disease of Bone has completed (status: COMPLETED).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paget Disease of Bone

Drugs mentioned

• MK0217

Snippet

Sponsor: Organon and Co | Conditions: Paget's Disease of Bone | Phase 3 | Status: COMPLETED